Discover the top trends shaping Pharma corporate venture capital in 2025. AI, machine learning, and gene therapy lead investments, with Google Ventures, Eli Lilly, EMD Serono, and AbbVie at the forefront. Focus is expanding beyond oncology to immune disorders, rare diseases, and neurodegenerative conditions. For full insights, access the complete report here: https://bit.ly/46zutfv

Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 Professional audiences only. Not investment research or advice. UK readers: […] The post Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 appeared first on LucidQuest Ventures.

RSL Collective launched a “Really Simple Licensing” layer on robots.txt, adding monetization terms for AI training with backing from major media. Eli Lilly unveiled TuneLab with insitro and Circle Pharma, leveraging $1B in data. The FDA cleared Apple Watch hypertension alerts and set a November 6 panel on AI mental-health tools. Neuralink eyes October trials of thought-to-text implants, while Norway approved Eyenuk’s AI eye screening. Meanwhile, new AMA AI billing codes arrive in 2026, marking a pivotal step in healthcare AI adoption

Catch the latest Oncology news, featuring ESMO 2025 updates, FDA and EMA milestones, clinical progress, and biopharma innovations. 🧬 Bicara […] The post Oncology Today – October 20, 2025 appeared first on LucidQuest Ventures.

 Here is your weekly brief that highlights the most relevant updates across AI and digital health at a glance. In […] The post AI in Healthcare and Digital Health Today—November 3, 2025 appeared first on LucidQuest Ventures.

Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional audiences only. Not investment research or advice. UK readers: […] The post Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery appeared first on LucidQuest Ventures.

Hematology Update: Cemsidomide–Elranatamab Combo, Ziftomenib AML Trial, Fast Track CAR T & More From C4–Pfizer’s cemsidomide–elranatamab partnership in myeloma to […] The post Hematology Weekly News – October 6th 2025 appeared first on LucidQuest Ventures.

In this video, we take a closer look at the newest updates in immunology. Watch for recent approvals, promising pipeline […] The post Immunology Video Recap—October 22, 2025 appeared first on LucidQuest Ventures.

Alzinova’s Alzheimer’s vaccine, ALZ-101, receives FDA Fast Track designation, with Phase 2 trials set to begin. Bavarian Nordic reports positive results for its mpox vaccine in children, while the University of Maryland and Bharat Biotech show strong Phase 1 data for a Salmonella vaccine. TransCode secures $25M to advance its Phase 3 melanoma vaccine, and Moderna releases promising Phase 1/2 data for its mRNA melanoma vaccine. Updates also include Everest, GC Biopharma, and SK Bioscience’s cancer and vaccine trials.

Les pharmaciens en colère ont annoncé leur intention de renforcer leur mobilisation à la rentrée après la publication au Journal officiel d’un arrêté entérinant la baisse des remises commerciales que ...

🧬 This Week in Immunology: robotic ESD milestone, pediatric AD access, in vivo CAR T, Treg Nobel, and more From […] The post Immunology Weekly News – October 8th 2025 appeared first on LucidQuest Ventures.

Lucid Diligence Brief: Verily UCHealth AI collaboration Professional audiences only. Not investment research or advice. UK readers: for persons under […] The post Lucid Diligence Brief: Verily UCHealth AI collaboration appeared first on LucidQuest Ventures.

Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration Professional audiences only. Not investment research or advice. UK […] The post Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration appeared first on LucidQuest Ventures.

Stay updated with this week’s obesity news, covering key developments and advancements across top biopharma companies. In this Newsletter 💊 […] The post Obesity Today— October 21, 2025 appeared first on LucidQuest Ventures.

Alzinova’s Alzheimer’s vaccine, ALZ-101, receives FDA Fast Track designation, with Phase 2 trials set to begin. Bavarian Nordic reports positive results for its mpox vaccine in children, while the University of Maryland and Bharat Biotech show strong Phase 1 data for a Salmonella vaccine. TransCode secures $25M to advance its Phase 3 melanoma vaccine, and Moderna releases promising Phase 1/2 data for its mRNA melanoma vaccine. Updates also include Everest, GC Biopharma, and SK Bioscience’s cancer and vaccine trials.

In this biweekly edition, we cover the most significant developments shaping the future of Gene & Cell Therapy — from […] The post Cell and Gene Therapy Video Recap – October 30, 2025 appeared first on LucidQuest Ventures.

This week’s Gene & Cell Therapy news delivers the latest updates, developments, and progress from leading biopharma companies. In Today’s […] The post Cell and Gene Therapy Today—October 30, 2025 appeared first on LucidQuest Ventures.

Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI Professional audiences only. Not investment […] The post Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI appeared first on LucidQuest Ventures.

This week’s neuroscience update spotlights key developments, regulatory milestones, and the latest progress shaping the biopharma landscape. In Today’s Newsletter […] The post Neuroscience Today — November 12, 2025 appeared first on LucidQuest Ventures.

Oncology Update: Enhertu Superiority, Tecentriq Combo Approval, New Trials & More! From Enhertu’s win over T-DM1 in early HER2-positive breast […] The post Oncology Weekly News – October 6th 2025 appeared first on LucidQuest Ventures.

Cardiovascular Update: Cardiovascular Aging Model, Next-Gen TAVR Platform  and More This week in cardiovascular news, we bring aging-centered care innovations, […] The post Cardiovascular Weekly News – September 18th 2025 appeared first on LucidQuest Ventures.

Vaccine Research Update: Pneumococcal Advances, Dengue Review, Cancer Data, and More! From Virometix completing enrollment in a Phase I trial […] The post Vaccines Weekly Update – October 3rd 2025 appeared first on LucidQuest Ventures.